DASAPOINT 50 MG (Dasatinib (50mg))

Dasapoint 50 mg is a medication commonly used to support patients with certain types of blood cancers, including chronic myeloid leukaemia and acute lymphoblastic leukaemia. It is part of a class of medicines known as tyrosine kinase inhibitors, which work to help manage the growth of cancer cells. By targeting specific proteins involved in cancer cell development, Dasapoint aims to slow down or stop the progression of these conditions, which may help improve the overall health and well-being of patients.

The active ingredient, Dasatinib, functions by inhibiting the action of certain enzymes that play a role in tumour growth. This approach allows the body to better control the cancerous cells, potentially leading to an improved outcome for those affected. It is important to take Dasapoint consistently as directed, and it should be stored in a cool, dry place, away from direct sunlight and moisture to maintain its effectiveness.

While many people tolerate Dasapoint well, some may experience mild side effects. These can include headaches, fatigue, nausea, and mild skin rashes. It is essential to monitor any changes in your health and discuss any concerns with your healthcare provider.

This is general information, not a substitute for medical advice. Always consult a doctor/pharmacist and read the package leaflet.